1,164
Views
31
CrossRef citations to date
0
Altmetric
Articles; Medical Biotechnology

Relationship between vitamin D status and immunosuppressive therapy in kidney transplant recipients

, , &
Pages 331-335 | Received 06 Oct 2014, Accepted 27 Oct 2014, Published online: 08 Jan 2015

References

  • Rojas-Rivera J, De La Piedra C, Ramos A, Ortiz A, Egido J. The expanding spectrum of biological actions of vitamin D. Nephrol Dial Transplant. 2010;25:2850–2865.
  • Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, Green MD, Jha V, Josephson MA, Kiberd BA, Kreis HA, McDonald RA, Newmann JM, Obrador GT, Vincenti FG, Cheung M, Earley A, Raman G, Abariga S, Wagner M, Balk EM. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int. 2009;77:299–311.
  • Stavroulopoulos A, Cassidy MJ, Porter CJ, Hosking DJ, Roe SD. Vitamin D status in renal transplant recipients. Am J Transplant. 2007;7:2546–2552.
  • Falkiewicz K, Boratynska M, Speichert-Bidzińska B, Magott-Procelewska M, Biecek P, Patrzalek D, Klinger M. 1,25-dihydroxyvitamin D deficiency predicts poorer outcome after renal transplantation. Transplant Proc. 2009;41:3002–3005.
  • Redaelli CA, Wagner M, Tien YH, Mazzucchelli L, Stahel PF, Schilling MK, Dufour JF. 1 alpha,25-dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts. Hepatology. 2001;34:926–934.
  • Tsiaras WG, Weinstock MA. Factors influencing vitamin D status. Acta Dermato Venereologica. 2011;91:115–124.
  • Querings K, Girndt M, Geisel J, Georg T, Tilgen W, Reichrath J. 25-hydroxyvitamin D deficiency in renal transplant recipients. J Clin Endocrinol Metab. 2006;91:526–529.
  • Moe SM, Drüeke TB, Block GA, Cannata-Andía JB, Elder GJ, Fukagawa M, Jorgetti V, Ketteler M, Langman CB, Levin A, MacLeod AM, McCann L, McCullough PA, Ott SM, Wang AY, Weisinger JR, Wheeler DC, Persson R, Earley A, Moorthi R, Uhlig K. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. 2009;76(Suppl 113):S1–130.
  • Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, Fuleihan GE, Josse RG, Lips P, Morales-Torres J. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;20:1807–1820.
  • Holick MF. Vitamin D deficiency. New England J Med. 2007;357:266–281.
  • McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J. 2008;7:1–5.
  • Grenet O, Bobadilla M, Chibout SD, Steiner S. Evidence for the impairment of the vitamin D activation pathway by cyclosporine A. Biochem Pharmacol. 2000;59:267–272.
  • Reichel H, Grüssinger A, Knehans A, Kühn K, Schmidt-Gayk H, Ritz E. Long-term therapy with cyclosporin A does not influence serum concentrations of vitamin D metabolites in patients with multiple sclerosis. Clin Investig. 1992;70:595–599.
  • Lee CT, Ng HY, Lien YH, Lai LW, Wu MS, Lin CR, Chen HC. Effects of cyclosporine, tacrolimus and rapamycin on renal calcium transport and vitamin D metabolism. Am J Nephrol. 2011;34:87–94.
  • Eyal O, Aharon M, Safadi R, Elhalel MD. Serum vitamin D levels in kidney transplant recipients: the importance of an immunosuppression regimen and sun exposure. Isr Med Assoc J. 2013;15:628–633.
  • Burkhalter F, Schaub S, Dickenmann M. Preserved circannual rhythm of vitamin D in kidney transplant patients. Swiss Med Weekly. 2012;142:1–7.